CEMI Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Apr 2023 @ 22:00):

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases...

Stats
Tagesvolumen	351 642
Durchschnittsvolumen	538 392
Marktkapitalisierung	16.71M
EPS	$0 ( 2024-03-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.632
ATR14	$0.0250 (5.49%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-11	Angelico Paul	Buy	29 333	Common Stock
2023-03-15	Angelico Paul	Buy	7 885	Common Stock
2023-03-15	Angelico Paul	Sell	2 843	Common Stock
2023-03-11	Angelico Paul	Sell	10 575	Common Stock
2023-03-11	Angelico Paul	Sell	29 333	Restricted stock units

INSIDER POWER
-90.29
Last 100 transactions
Buy: 781 277 \| Sell: 10 790 554

Volumen Korrelation

Lang: 0.06 (neutral)

Kurz: 0.14 (neutral)

Signal:(58.078) Neutral

Chembio Diagnostics Inc Korrelation

10 Am meisten positiv korreliert
EWCZ	0.948
FTDR	0.94
NPCE	0.938
HEWG	0.937
DXGE	0.932
ULTA	0.931
WBD	0.925
GLBE	0.916
ROBT	0.916
NRC	0.912

10 Am meisten negativ korreliert
ADXN	-0.922
MHUA	-0.913
AHPI	-0.898
BAFN	-0.898
SBNY	-0.89
ESPR	-0.889
RAIL	-0.888
KZR	-0.886
IGMS	-0.884
LOCO	-0.883

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Chembio Diagnostics Inc Korrelation - Währung/Rohstoff

-0.48
( neutral )

0.37
( neutral )

0.00
( neutral )

-0.12
( neutral )

0.67
( moderate )

0.56
( weak )

Chembio Diagnostics Inc Finanzdaten

Annual	2022
Umsatz:	$48.34M
Bruttogewinn:	$9.76M (20.19 %)
EPS:	$-0.960

FY	2022
Umsatz:	$48.34M
Bruttogewinn:	$9.76M (20.19 %)
EPS:	$-0.960

FY	2021
Umsatz:	$47.82M
Bruttogewinn:	$13.32M (27.86 %)
EPS:	$-1.400

FY	2020
Umsatz:	$30.45M
Bruttogewinn:	$6.58M (21.60 %)
EPS:	$-1.340

Financial Reports:

No articles found.

Chembio Diagnostics Inc

Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.